- Home
- INSE vs SGMT Comparison
INSE vs SGMT Comparison
Compare INSE & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INSE | SGMT |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.3M | 238.7M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | INSE | SGMT |
|---|---|---|
| Price | $8.92 | $6.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $13.50 | ★ $29.71 |
| AVG Volume (30 Days) | 182.0K | ★ 638.9K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $309,900,000.00 | N/A |
| Revenue This Year | $4.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.66 | ★ N/A |
| Revenue Growth | ★ 4.98 | N/A |
| 52 Week Low | $6.51 | $1.73 |
| 52 Week High | $11.61 | $11.41 |
Technical Indicators
Market Signals| Indicator | INSE | SGMT |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 38.53 |
| Support Level | $8.79 | $5.77 |
| Resistance Level | $9.34 | $6.93 |
| Average True Range (ATR) | 0.42 | 0.45 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 53.15 | 25.32 |
Price Performance
Historical ComparisonAbout INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.